Helix BioPharma Corp. Announces CAR-T Poster Presentation at the AACR Conference
Marketwire Canada - Thu Sep 01, 6:30AM CDT
CAR-T Cells Harboring Camelid Single Domain Antibody as Targeting Agent to CEACAM6 Antigen in Pancreatic Cancer
HBP: 6.36 (-0.14), HBP.TO: 1.87 (unch)
Huttig Building Products, Inc. Announces Second Quarter 2016 Results
Marketwire Canada - Mon Aug 01, 3:30PM CDT
ST. LOUIS, MO--(Marketwired - August 01, 2016) -
HBP: 6.36 (-0.14)
Helix BioPharma Corp. Closes CAD1.8 Million Private Placement
Marketwired - Fri Jul 29, 3:01PM CDT
AURORA, ON--(Marketwired - Jul 29, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"
HBP: 6.36 (-0.14), HBP.TO: 1.87 (unch)
Helix BioPharma Corp. Appoints Evolution Life Science Partners as Advisors
Marketwired - Thu Jun 02, 7:00AM CDT
AURORA, ON--(Marketwired - Jun 2, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"
HBP: 6.36 (-0.14), HBP.TO: 1.87 (unch)
Huttig Adopts Rights Plan to Protect Net Operating Loss Carryforwards
Marketwire Canada - Thu May 19, 3:30PM CDT
ST. LOUIS, MO --(Marketwired - May 19, 2016) - Huttig Building Products, Inc. ("Huttig"
HBP: 6.36 (-0.14)
First Patient Dosed in Phase II Study of L-DOS47 in Non-Small Cell Lung Cancer
Marketwire Canada - Wed May 11, 6:30AM CDT
AURORA, ON--(Marketwired - May 11, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"
HBP: 6.36 (-0.14), HBP.TO: 1.87 (unch)
Helix BioPharma Corp. Subsidiary, Helix Polska Sp zo.o., Qualifies for CAD4.1 Million Grant From the Polish National Center for Research and Development
Marketwire Canada - Mon May 09, 6:30AM CDT
AURORA, ON--(Marketwired - May 9, 2016) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"
HBP: 6.36 (-0.14), HBP.TO: 1.87 (unch)
Huttig posts 1Q profit
Automated Insights - Mon May 02, 3:57PM CDT
ST LOUIS (AP) _ Huttig Building Products Inc. (HBP) on Monday reported profit of $1.4 million in its first quarter.
HBP: 6.36 (-0.14)
Huttig Building Products, Inc. Announces First Quarter 2016 Results
Marketwired - Mon May 02, 3:30PM CDT
First Quarter 2016 Highlights:
HBP: 6.36 (-0.14)
Helix BioPharma Corp. Closes CAD4.7 Million Private Placement Financing
Marketwired - Fri Apr 29, 6:30AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"
HBP: 6.36 (-0.14), HBP.TO: 1.87 (unch)
First Patient Enrolled in Phase II Study of L-DOS47 in Non-Small Cell Lung Cancer
Marketwire Canada - Thu Apr 28, 6:30AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"
HBP: 6.36 (-0.14), HBP.TO: 1.87 (unch)
Trial Steering Committee Recommends Initiation of Phase II L-DOS47 Study in Non-Small Cell Lung Cancer
Marketwire Canada - Thu Apr 21, 4:00AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) ("Helix" or the "Company"
HBP: 6.36 (-0.14), HBP.TO: 1.87 (unch)